Articles

Histone deacetylase inhibition sensitizes p53-deficient B-cell precursor acute lymphoblastic leukemia to chemotherapy

Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Oncode Institute, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Genetics, Utrecht University Medical Center, Utrecht University, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Haematologica Early view Dec 21, 2023 https://doi.org/10.3324/haematol.2023.284101